16+
Major trials tracked
Immunology & inflammation · Live ClinicalTrials.gov data
Risankizumab (Skyrizi) clinical trial pipeline
The timeline below tracks the 16 largest phase 2–4 risankizumab (Skyrizi) trials on ClinicalTrials.gov by enrolment, 2 of them actively recruiting. The next phase 3 primary completion among them is expected Jan 2027. Refreshed daily. Add up to four competitors to compare pipelines side by side.
10
Phase 3 trials
2
Actively recruiting
Jan 2027
Next phase 3 primary completion
8,433
Participants across trials
AbbVie
Lead sponsor by trial count
risankizumab (16)7 active2016–2030
risankizumab
'16
'18
'20
'22
'24
'26
'28
'30
risankizumab
BI 655066 (Risankizumab) Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque PsoriasisP3
BI 655066 / ABBV-066 (Risankizumab) in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatmentP3
BI 655066/ABBV-066 (Risankizumab) Compared to Active Comparator (Adalimumab) in Patients With Moderate to Severe Chronic Plaque PsoriasisP3
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic TreatmentP3
A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative ColitisP2
COMMANDP3
DETERMINED 1P2
A Study of the Safety and Efficacy of Risankizumab in Adult Participants With Plaque Psoriasis Who Have Had a Suboptimal Response to Secukinumab or IxekizumabP3
PSORIASI_RISAP4
Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic TherapyP4
SOPRANO-CDP4
UnlIMMitedP4
AFFIRMP3
IZAR-2P3
Risankizumab for Fibrostenotic Crohn's Disease TreatmentP3
CHARGEP3
Upcoming readouts
6 ahead · risankizumab
Select a trial to load its full ClinicalTrials.gov record.
Key risankizumab trials
Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.
Track risankizumab with ComplyRx
Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.
Related drug pipelines
FAQ
- How many clinical trials are running for risankizumab?
- ClinicalTrials.gov lists more than 16 phase 2–4 risankizumab trials. This page tracks the 16 largest by enrolment: 2 phase 2, 10 phase 3, and 4 phase 4 among them, with 2 actively recruiting. Updated daily.
- Are there clinical trials for Skyrizi?
- Skyrizi is the brand name for risankizumab, so risankizumab trials on ClinicalTrials.gov cover it. ClinicalTrials.gov lists more than 16 phase 2–4 risankizumab trials. This page tracks the 16 largest by enrolment: 2 phase 2, 10 phase 3, and 4 phase 4 among them, with 2 actively recruiting. Updated daily.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
- Can I compare risankizumab against other drugs?
- Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
